Cammà C - Search Results

1

Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials.

Cammà C, Giunta M, Pinzello G, Morabito A, Verderio P, Pagliaro L. Cammà C, et al. Am J Gastroenterol. 1999 Mar;94(3):581-95. doi: 10.1111/j.1572-0241.1999.00919.x. Am J Gastroenterol. 1999. PMID: 10086636

2

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R, et al. Simonetti RG, et al. Among authors: camma c. Ann Intern Med. 1992 Jan 15;116(2):97-102. doi: 10.7326/0003-4819-116-2-97. Ann Intern Med. 1992. PMID: 1309286

3

Hepatitis C virus antibodies in chronic liver diseases of different aetiology.

Craxi A, Almasio P, Di Marco V, Magrin S, Bruno R, Cammà C, Fiorentino G, Lo Jacono O, Marino L, Palazzo U, et al. Craxi A, et al. Among authors: camma c. Ital J Gastroenterol. 1991 Jun;23(5):244-8. Ital J Gastroenterol. 1991. PMID: 1742513

4

Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.

Craxì A, Tinè F, Vinci M, Almasio P, Cammà C, Garofalo G, Pagliaro L. Craxì A, et al. Among authors: camma c. Am J Epidemiol. 1991 Sep 15;134(6):641-50. doi: 10.1093/oxfordjournals.aje.a116136. Am J Epidemiol. 1991. PMID: 1951268

5

Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.

Cammà C, Fiorello F, Tinè F, Marchesini G, Fabbri A, Pagliaro L. Cammà C, et al. Dig Dis Sci. 1993 May;38(5):916-22. doi: 10.1007/BF01295920. Dig Dis Sci. 1993. PMID: 8482191 Clinical Trial.

6

Interferon as treatment for acute hepatitis C. A meta-analysis.

Cammà C, Almasio P, Craxì A. Cammà C, et al. Dig Dis Sci. 1996 Jun;41(6):1248-55. doi: 10.1007/BF02088245. Dig Dis Sci. 1996. PMID: 8654160

7

Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 months.

Craxì A, Di Marco V, Lo Iacono O, Almasio P, Bruno R, Cammà C, Volpes R, Pagliaro L. Craxì A, et al. Among authors: camma c. J Hepatol. 1996 May;24(5):539-46. doi: 10.1016/s0168-8278(96)80138-3. J Hepatol. 1996. PMID: 8773908 Clinical Trial.

8

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.

Di Marco V, Lo Iacono O, Cammà C, Almasio PL, Vaccaro A, Fuschi P, Giunta M, Fabiano C, Pagliaro L, Craxì A. Di Marco V, et al. Among authors: camma c. J Med Virol. 1997 Jan;51(1):17-24. doi: 10.1002/(sici)1096-9071(199701)51:1<17::aid-jmv3>3.0.co;2-v. J Med Virol. 1997. PMID: 8986944 Clinical Trial.

9

Duration of HCV infection as a predictor of nonresponse to interferon.

Craxì A, Di Marco V, Cammà C, Almasio P, Magrin S. Craxì A, et al. Among authors: camma c. Dig Dis Sci. 1996 Dec;41(12 Suppl):86S-92S. doi: 10.1007/BF02087881. Dig Dis Sci. 1996. PMID: 9011482

10

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.

Cammà C, Giunta M, Linea C, Pagliaro L. Cammà C, et al. J Hepatol. 1997 Jun;26(6):1187-99. doi: 10.1016/s0168-8278(97)80451-5. J Hepatol. 1997. PMID: 9210603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results